Related Links
ARALAST NP AATmosphere Program
Support for Alphas and families from the ARALAST NP AATmosphere program.
What to Expect
Once you and your doctor have agreed on augmentation therapy, you'll want to understand what will be involved in the therapy process. Here is important information about what you can expect when your augmentation therapy begins.
You will receive your ARALAST NP therapy through an infusion, which means that an intravenous (IV) line will be used to get the ARALAST NP therapy into your bloodstream. The infusion will be administered by a healthcare professional, such as a doctor or nurse. Most people receive ARALAST NP infusions once a week.
Selecting a Location
Depending upon your insurance coverage, your personal preference, and what you and your healthcare provider think might be best for you, you may receive your infusions in:
- your home
- your workplace
- a hospital outpatient department
- a freestanding infusion center or clinic
If you decide to receive your ARALAST NP therapy at home or in your workplace, a specialized homecare company will help you with all the arrangements.
You and your healthcare provider can select the homecare company that best fits your needs. To learn more about the homecare companies available to ARALAST NP patients, visit the Home Care page of this website.
Home Care and Your Therapy
Once you have selected a homecare company, your healthcare provider will contact the company to begin the process.
First, you will receive a call from your specialized homecare agency – usually within a week of deciding that augmentation therapy is right for you. Together, you will set up the time and dates for your infusions.
When the homecare nurse arrives to administer your treatments, he or she will bring everything needed for your infusion. The complete infusion process, including set-up, usually takes about an hour.
Even though you will be getting infusions every week, you will continue to see your doctor regularly. Any questions you have about your therapy or care of your infusion site can be answered by your doctor, your homecare agency, and/or the nurse who administers your therapy.
ARALAST NP [Alpha1-Proteinase Inhibitor (Human)]
ARALAST NP is indicated for chronic augmentation therapy in patients having congenital deficiency of A1-PI with clinically evident emphysema. ARALAST NP is not indicated as therapy for lung disease patients in whom congenital A1-PI deficiency has not been established.
The effect of augmentation therapy with ARALAST NP on pulmonary exacerbations and on the progression of emphysema in alpha1-antitrypsin deficiency has not been demonstrated in randomized, controlled clinical trials.
Please review the Important Risk Information and the Full Prescribing Information
Please review the Important Risk Information and the Full Prescribing Information
